This report examines the utilization of oral antiviral medications, Paxlovid and Lagevrio, for the treatment of COVID-19. The analyses include an examination of time trends of COVID-19 antiviral use as well as breakdowns by age cohorts and gender. The report finds that utilization in the U.S.
COVID-19
Reports
Displaying 21 - 30 of 76. 10 per page. Page 3.
Advanced SearchASPE Issue Brief
COVID-19 Antivirals Utilization: Geographic and Demographic Patterns of Treatment in 2022
Research Brief
Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines
In April 2021 the U.S. Department of Health and Human Services (HHS) issued revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (Practice Guideline).
ASPE Issue Brief
State Medicaid Telehealth Policies Before and During the COVID-19 Public Health Emergency: 2022 Update
This issue brief provides updates on state Medicaid policies regarding delivery of telehealth services by provider types and modalities, as of January 2022. The COVID-19 pandemic substantially accelerated interest in and utilization of telehealth across all payers including Medicaid.
ASPE Issue Brief
Racial/Ethnic Differences in Children’s Mental Health Services Use Before and During the COVID-19 Pandemic Issue Brief
Using a national Medicaid database, the report shows significant racial/ethnic disparities in mental health service use among children during the COVID-19 pandemic.
ASPE Issue Brief
Reductions in Deaths and Hospitalizations Associated with COVID-19 Vaccinations Among Medicare Beneficiaries: Full Year 2021 Estimates
This study updates ASPE’s previous analysis of the associations between COVID-19 hospitalizations and deaths among Medicare beneficiaries and COVID-19 vaccination rates, with full year data through the end of 2021.
ASPE Issue Brief, Research Brief
Nursing Home Staffing and the COVID-19 Pandemic
It is well known that in the early weeks of the COVID-19 pandemic in the United States much of the devastation was concentrated in nursing homes. In addition to the staggering death toll, isolation and suffering from COVID-19 among nursing home residents, the pandemic introduced new challenges for nursing home staff and exacerbated ongoing challenges.
ASPE Issue Brief, Database, Dataset
Flexibilities in Controlled Substances Prescribing and Dispensing During the COVID-19 Pandemic
The COVID-19 pandemic had wide-ranging impacts on health care delivery, particularly services that require in-person interactions. For patients needing access to medications to treat pain or certain substance use disorders, the COVID-19 pandemic presented particular challenges for continuity of treatment.
ASPE Issue Brief
Unwinding the Medicaid Continuous Enrollment Provision: Projected Enrollment Effects and Policy Approaches
This report provides current HHS projections of the number of individuals predicted to lose Medicaid coverage at the end of the COVID-19 public health emergency (PHE) due to a change in eligibility or due to administrative churning.
ASPE Issue Brief
Connecting Youth During the COVID-19 Pandemic
This infographic explores the impact the COVID-19 pandemic had on programs that support young people, ages 16-24, who experience disconnection from school and work, often referred to as "opportunity youth." It provides an overview of which education, job training, and supportive services, in addition to enrollment and implementation practices were added or ended during the first year (spring 20
ASPE Data Point
Hospitalization Cost Savings Associated with COVID-19 Vaccinations Among Medicare Beneficiaries in Early 2021
Using Medicare FFS claims data and county-level vaccination rates, we estimate savings of about $2.6 billion from reduced Medicare hospitalizations associated with COVID-19 vaccinations in early 2021.